Newtown Square, Pa. – Boiron, the leading manufacturer of Arnica homeopathic medicines, has given its Arnicare line of topicals a “face lift” with a brand new look and package.
The packaging has been updated with new product features and floral graphics that highlight the natural benefits of the product. The packaging is also color-coded to differentiate each formula: cream, gel and ointment. Arnicare Gel has a new prominent blue flower design, Arnicare Cream is represented by green, and Arnicare Ointment features purple.
While Arnicare may look different, what hasn’t changed is the safety and value of these topical medicines, which are popular among plastic surgery patients, serious and casual athletes, and active consumers. These topicals offer a natural and safe solution to pain relief. Containing homeopathic Arnica montana, also known as a mountain plant from the daisy family, Arnicare provides localized relief of muscles aches, stiffness, swelling and discoloration from bruises.
Regulated as a drug by the U.S. Food and Drug Administration, Arnicare topicals are manufactured according to the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices. Additionally, the formulas are paraben-free and do not contain artificial colors or perfumes. Visit www.arnicare.com for more information.
 U.S. Food and Drug Administration. Sec 400.400 Conditions Under Which Homeopathic Drugs May be Marketed (CPG7132.15). Available at: www.fda.gov/ora/compliance_ref/cpg/cpgdrg/cpg400-400.html.
About Boiron: Boiron, world leader in homeopathic medicines, is a $852 million public company with 3,700 employees and distribution in 59 countries. It is best known for Oscillococcinum®, a top-selling flu medicine, and its Arnicare® line of pain relievers. For more than 80 years, Boiron has been committed to funding scientific research and educating the public and healthcare professionals on homeopathic medicines. As a pharmaceutical company, Boiron maintains the highest standards in manufacturing, complying with U.S. Food and Drug Administration regulations, the Homeopathic Pharmacopoeia of the United States and drug Good Manufacturing Practices.